About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
exaly
›
Institutions
›
Mayo Clinic College of Medicine and Science
›
Division of Hematology
›
Top Articles
Division of Hematology
Mayo Clinic College of Medicine and Science
531
Articles
24.8K
Citations
3.6
avg. Impact Factor
87
h-index
Most Cited Articles of Division of Hematology in 2004
Title
Journal
Year
Citations
Clinical course of patients with relapsed multiple myeloma
Mayo Clinic Proceedings
2004
266
High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus
Cancer Research
2004
237
Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome
Blood
2004
193
Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivo
Blood
2004
148
Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later
Mayo Clinic Proceedings
2004
138
Imatinib targets other than bcr/abl and their clinical relevance in myeloid disorders
Blood
2004
110
Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma
Mayo Clinic Proceedings
2004
69
Thalidomide: tragic past and promising future
Mayo Clinic Proceedings
2004
68
Durable responses to thalidomide-based drug therapy for myelofibrosis with myeloid metaplasia
Mayo Clinic Proceedings
2004
57
Ethical issues in geriatrics: a guide for clinicians
Mayo Clinic Proceedings
2004
45
Detection of genetic variants of transthyretin by liquid chromatography-dual electrospray ionization fourier-transform ion-cyclotron-resonance mass spectrometry
Clinical Chemistry
2004
42
Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance
British Journal of Haematology
2004
40
Myelofibrosis with myeloid metaplasia: new developments in pathogenesis and treatment
Internal Medicine
2004
33
Advances in Screening, Diagnosis, and Treatment of Breast Cancer
Mayo Clinic Proceedings
2004
25
Yttrium-90-ibritumomab tiuxetan radioimmunotherapy: a new treatment approach for B-cell non-Hodgkin's lymphoma
Drugs of Today
2004
25
Current approach to diagnosis and management of chronic lymphocytic leukemia
Mayo Clinic Proceedings
2004
24
Therapeutic options in patients with lymphoma and severe liver dysfunction
Mayo Clinic Proceedings
2004
23
Primer on medical genomics. Part XIII: Ethical and regulatory issues
Mayo Clinic Proceedings
2004
22
Morbidity and mortality of deep sedation in outpatient bone marrow biopsy
American Journal of Hematology
2004
19
Advances in screening, diagnosis, and treatment of breast cancer
Mayo Clinic Proceedings
2004
18
Clinical-grade manufacturing of DC from CD14+ precursors: experience from phase I clinical trials in CML and malignant melanoma
Cytotherapy
2004
17
Severe, reversible pulmonary hypertension in a patient with monoclonal gammopathy and features of dermatomyositis
Mayo Clinic Proceedings
2004
17
Fatal coronary artery disease after unrelated donor bone marrow transplantation
Mayo Clinic Proceedings
2004
13
G-CSF Administration Increases Pulmonary Toxicity for Hodgkin’s Disease Patients Treated with Bleomycin-Containing Chemotherapy.
Blood
2004
4
Anagrelide: an update on its mechanisms of action and therapeutic potential
Expert Review of Anticancer Therapy
2004
3
Schools/Departments
The list of schools/departments is not comprehensive since it is common to drop the department in the affiliation.
site/software ©
exaly
; All materials licenced under
CC by-SA
.